Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Corona Remedies Limited Call Transcript 2026

Jan 5, 2026

59164_rns_2026-01-05_e63c9544-7301-4be1-bd54-e94cc143689a.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [596 x 118] intentionally omitted <==

January 05, 2026

To, Listing Operation Department BSE Limited P. J. Towers, Dalal Street, Mumbai - 400001 (BSE Scrip Code: 544644)

To, Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai– 400051 (SYMBOL: CORONA)

Dear Sir / Madam,

Sub.: Audio Recording of conference call with Analyst / Investor on Financial Results for the second quarter and half year ended September 30, 2025

In continuation to our letter dated December 30, 2025 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of conference call with Analyst / Investor on Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2025 is available on the website of the Company at:

https://www.coronaremedies.com/wp-content/uploads/2026/01/CORONA_Remedies_Q2FY26_Earnings-Call-_Audio.mp3

You are requested to take note of the above.

Thanking you.

Yours faithfully,

For CORONA Remedies Limited

Digitally signed by CHETNA CHETNA PRABHAT PRABHAT KUMAR KUMAR DHARAJIYA DHARAJIYA Date: 2026.01.05 15:58:12 +05'30'

Chetna Dharajiya Company Secretary and Compliance Officer